Published in Pharma Law Weekly, November 24th, 2009
"Data were analyzed using mixed-effects models and meta-regression. Overall, behavioral interventions had a significant impact on reductions in HIV-risk sex behaviors (odds ratio [OR]= 0.63; 95% confidence interval [CI] = 0.54, 0.75; n = 11239; Cochrane Q(32) = 84.73; P< .001) and sexually transmitted infections...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly